Medtronic has agreed to be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes devices that provide revascularization treatment for carotid and peripheral vascular disease.

New Medtronic CFO Thierry Piéton. [Image from Mobilize Financial Services] Medtronic (NYSE: MDT) + announced today that it appointed Thierry Piéton as its new chief financial officer (CFO ...

The MiniMed 780G with the Simplera Sync CGM and accompanying devices. [Image courtesy of Medtronic] The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline ...

Medtronic’s Percept PC neurostimulator with BrainSense technology [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced today that it received CE mark approval for its BrainSense ...

Innovation has “created a tailwind for the company that that we haven’t had in a long time,” Medtronic CEO Geoff Martha said at the 2025 J.P. Morgan Healthcare Conference. “These are growth-drivers ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price target of $100.00. Discover outperforming stocks and invest ...

At the 43rd annual J.P. Morgan Healthcare Conference on Monday, Medtronic CEO Geoff Martha mixed in some breaking news with his usual pitch to investors. Just hours earlier, the Centers for ...

This study evaluates the benefits of a novel AR platform, VOSTARS, by comparing its targeting accuracy to that of the gold-standard electromagnetic (EM) navigation system, Medtronic StealthStation ® ...

Parkhill's exit came months after Medtronic, as part of a turnaround, decided to exit its unprofitable ventilator product line within its patient monitoring and respiratory interventions (PMRI ...

SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a European approval for what it describes as ...